Paul Robberts

Paul Robberts has extensive experience in various leadership roles across multiple sectors, particularly in pharmaceuticals and real estate. Currently serving as a board member at Kamer van Gerlach since September 2021, Robberts is also a managing partner at Cresco Pharma B.V. since 2007, focusing on pharmaceutical projects including antibiotics and Parkinson's disease treatments. Robberts holds the position of seed funder at Vixiar Medical and is a partner at Maatschap "Heeren van Oranje," which manages real estate portfolios. Additional roles include managing director at Kacero Holding, specializing in real estate management and venture capital, and as DGA at Robotronics BV, focusing on specialized medical equipment. Previous experience includes directorship at Syrolab BV and involvement in new business development at Mediq BV. Educational background includes a degree in Gymnasium bèta from Delft University of Technology and Stella Maris College Meerssen.